We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current AVTE market cap is 76.81M. The company's latest EPS is USD -2.6155 and P/E is -1.02.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -21.37M | -22.07M | -24.62M | -26.17M | -17.41M |
| Net Income | -19.56M | -20.41M | -23.19M | -24.78M | -16.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.33M | -8.89M | -23.02M | -53.24M | -81.41M |
| Net Income | -3.33M | -9.61M | -22.96M | -51.51M | -75.52M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 140.88M | 127.42M | 106.82M | 111.69M | 90.96M |
| Total Liabilities | 15.15M | 17.96M | 15.92M | 17.3M | 10.47M |
| Total Equity | 125.72M | 109.46M | 90.9M | 94.4M | 80.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.51M | 4.72M | 175.36M | 135.3M | 127.42M |
| Total Liabilities | 657k | 1.77M | 2.95M | 8.56M | 17.96M |
| Total Equity | -3.64M | -13.34M | 172.42M | 126.74M | 109.46M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -41.98M | -56.78M | -23.67M | -44.11M | -60.15M |
| Investing | 6.23M | 11.88M | 8.83M | 26.83M | 42.9M |
| Financing | 45.53M | 46M | 471k | 24.85M | 24.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.78M | -7.86M | -27.4M | -39.12M | -56.78M |
| Investing | N/A | N/A | -113.43M | 6.93M | 11.88M |
| Financing | 2.5M | 8.92M | 190.46M | 396k | 46M |
| Market Cap | 76.81M |
| Price to Earnings Ratio | -1.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.27 |
| Price to Book Ratio | 0.7 |
| Dividend Yield | - |
| Shares Outstanding | 28.87M |
| Average Volume (1 week) | 94.04k |
| Average Volume (1 Month) | 186.61k |
| 52 Week Change | -88.18% |
| 52 Week High | 32.415 |
| 52 Week Low | 1.25 |
| Spread (Intraday) | 1.61 (41.28%) |
| Company Name | Aerovate Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aerovatetx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
